Oncology Biomarker Diagnostics

Linking molecular status to breakthroughs in cancer treatment

Scientific Advisors

 

Arul M. Chinnaiyan, M.D., Ph.D.
Director, University of Michigan Center for Translational Pathology

 

Brian Druker, M.D.
Director, Oregon Health and Science University Knight Cancer Institute

Oncology Thought Leaders Series:
Brian Druker, MD speaks on the value of
companion diagnostics in patient outcomes